mywealthgrid
Overview
Dashboard
My workspace
My PortfolioWatchlistsFollowingScreenersAlertsResearch
Discover
CompaniesSectorsIndicesMutual fundsInstitutional investorsCompareTrade trends
Market updates
ResultsAnnouncementsSearch filingsCalendarUpcoming listings
Sign in to save your work
Sign inSign up
Loading page…
SP

Shukra Pharmaceuticals Ltd

BSE:SHUKRAPHAR
HealthcarePharmaceuticals & Biotechnology
₹61.8
-0.47%1 Oct close
Mkt cap
₹2,706 Cr
Watch Alert Compare
OverviewChartPeersProfit & lossBalance sheetCash flowRatiosShareholdingF&ODocumentsEventsAnnouncementsNotes
AnnualQuarterly

Standalone figures · ₹ crore · years without a filed annual are summed from quarters

₹ CrMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
5556101120597533
COGS-2-1-1-1-331045-44-8
Gross profit—————81014——
55551377810028
Operating profit (EBITDA)112201351913
OPM %28.6%28.6%29.1%30.6%1.3%12.9%14.1%9.1%26%39.1%
Depreciation1011112223
Interest—————00001
0—00—00134
Profit before tax011100142013
Tax—0-00—-00014
Tax %—35.5%-1.1%61.8%—-90%26.5%0.9%6.8%28.2%
011000141910
PAT margin %4.6%13.7%16.6%5.1%0.6%1.7%3.7%7.5%24.9%29.4%
EPS (₹)0.10.5——0.41.24.826.214.31.1
EPS adjusted (₹)—————00.10.30.40.2
0%0%——0%0%10.4%1.9%7%0.9%
Annual reportAnnual report for Mar 2016Annual report for Mar 2017Annual report for Mar 2018Annual report for Mar 2019Annual report for Mar 2020Annual report for Mar 2021Annual report for Mar 2022Annual report for Mar 2023Annual report for Mar 2024Annual report for Mar 2025

₹ CrMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Equity capital2241144
Reserves1415214719
Minority interest——0——
103534
1015451720
Total equity & liabilities3635757887
1818202019
CWIP22222
Investments000——
1616535665
Total assets3635757887

₹ CrMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
183-58
-2-2-4-1-1
2-7512-5
Net cash flow0-0462
Free cash flow-16-1-58
CFO / Operating profit %37.5%269.2%59.1%-26.8%62.2%

Compounded sales growth

7 years
29%
5 years
26%
3 years
17%
1 year
-56%

Compounded profit growth

7 years
40%
5 years
176%
3 years
134%
1 year
-48%

Stock price CAGR

10 years
—
5 years
—
3 years
—
1 year
83%

Return on equity

7 years
—
5 years
14%
3 years
22%
Last year
15%